Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Functional imaging in brain tumors].

Katalin Borbély1

  • 1Országos Idegsebészeti Tudományos Intézet Nukleáris Medicina Osztály. borbkat@mailer.oiti.hu

Orvosi Hetilap
|April 6, 2004
PubMed
Summary

Positron emission tomography (PET) offers advanced imaging for brain tumors, improving diagnosis and therapy monitoring beyond standard methods. PET techniques like 18F-FDG and 11C-methionine enhance differentiation of tumor grades and recurrence from necrosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brainstem Glioma Prognostication: Static FET PET/CT.

Cancers·2025
Same author

[The clinical impact of amino acid positron emission tomography measurements in the treatment of primary malignant brain tumors].

Orvosi hetilap·2023
Same author

Therapy Defining at Initial Diagnosis of Primary Brain Tumor-The Role of <sup>18</sup>F-FET PET/CT and MRI.

Biomedicines·2023
Same author

Use of Diagnostic Imaging Modalities in Modern Screening, Diagnostics and Management of Breast Tumours 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.

Pathology oncology research : POR·2022
Same author

PET/MRI in the Presurgical Evaluation of Patients with Epilepsy: A Concordance Analysis.

Biomedicines·2022
Same author

[Nuclear medicine techniques in the diagnosis of pancreatic cancer].

Magyar onkologia·2021

Area of Science:

  • Neuroimaging
  • Oncology
  • Nuclear Medicine

Background:

  • Conventional imaging (CT, MRI) excels in anatomical detail but struggles to differentiate tumor grades and post-treatment changes.
  • Distinguishing low-grade from high-grade gliomas and tumor recurrence from radiation necrosis remains a clinical challenge.
  • There is a need for functional imaging techniques to assess tumor metabolism and guide treatment decisions.

Purpose of the Study:

  • To evaluate the role of radionuclide imaging, particularly positron emission tomography (PET), in the diagnosis and monitoring of intracranial tumors.
  • To highlight the capabilities of PET in assessing tumor metabolism and differentiating tumor types and treatment effects.
  • To explore the potential of various PET radioligands in clinical practice.

Main Methods:

  • Review of PET techniques including 18F-FDG, 11C-methionine, and 11C-thymidine for brain tumor assessment.
  • Comparison of PET's metabolic information with anatomical data from CT and MRI.
  • Discussion of PET's utility in guiding biopsies, surgical planning, and differentiating neoplastic tissue from necrosis.

Main Results:

  • 18F-FDG PET accurately measures glucose metabolism to discriminate low-grade from high-grade lesions and recurrence from necrosis.
  • 11C-methionine PET delineates tumor boundaries, aiding stereotactic biopsy and surgical planning by identifying metabolically active neoplasm.
  • PET provides crucial functional insights beyond anatomical imaging, supporting diagnosis and therapy monitoring.

Conclusions:

  • Positron emission tomography (PET) significantly enhances the diagnosis and monitoring of intracranial tumors by assessing metabolic activity.
  • Multimodality imaging combining PET with CT/MRI is likely to become the standard for comprehensive brain tumor management.
  • PET radioligands offer valuable information for differentiating tumor grades, recurrence, and treatment-induced changes, improving patient care.

Related Experiment Videos